2020 Episode 8 – Cardiorenal Protection in Patients with Diabetes and CKD
Update: 2020-10-20
Description
Listen to leading experts discuss the new Scientific Statement from the American Heart Association, "Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease," where two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
